Smooth muscle–specific PFKFB3-knockout mice exhibit attenuated hypoxia-induced PAH, and PFKFB3 inhibitors alleviate pulmonary arterial remodeling by inhibiting PASMC proliferation (15). This evidence concerns the gene PFKFB3 and pulmonary arterial hypertension.